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Prospective study of autism
phenomenology and the behavioural
phenotype of Phelan–McDermid syndrome:
comparison to fragile X syndrome, Down
syndrome and idiopathic autism spectrum
disorder
Caroline Richards1*, Laurie Powis1,2, Jo Moss1,3, Christopher Stinton4, Lisa Nelson1 and Christopher Oliver1
Abstract
Background: The limited behavioural phenotype literature on Phelan–McDermid syndrome (PMS) indicates
atypically high levels of activity, impulsivity and autism spectrum disorder (ASD) behaviours. Divergent profiles of
ASD in PMS are also reported, with some studies demonstrating similarities to idiopathic ASD and others indicating
an uneven profile of social and communication impairments and repetitive behaviours. An evaluation of the
behavioural phenotype of PMS and the prevalence and phenomenology of ASD is warranted, particularly given the
causal involvement of the SHANK3 gene in the aetiology of PMS.
Methods: Carers of individuals with PMS (N = 30; mean age = 10.55, SD = 7.08) completed questionnaires relating
to impulsivity, overactivity, mood, interest and pleasure, repetitive behaviour and ASD phenomenology. These data
were compared to data from matched samples of individuals with fragile X and Down syndromes and idiopathic
ASD. In order to evaluate the profile of ASD phenomenology in PMS, two comparisons were made: first, including
the total sample with PMS, and second, including only those who met the threshold indicative of autism on an
ASD screening measure.
Results: The results revealed lower mood in individuals with PMS, but no differences in impulsivity and overactivity.
Compulsive and routine-driven repetitive behaviours were less common in the total sample with PMS; however,
motor-based stereotyped behaviours were more common. ASD phenomenology was highly prevalent, with 87% of
the sample meeting the cutoff score for ASD and 57% meeting the cutoff for autism. The profile of ASD
phenomenology in the total sample with PMS differed from those with idiopathic ASD across impairments in
communication and social interaction and repetitive behaviour. However, the profile of those who met the
threshold for autism was commensurate to those with idiopathic ASD.
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Conclusions: ASD phenomenology is common within PMS. Whilst the total sample may display an atypical profile
of ASD behaviour, the profile in those who met the threshold for autism was very similar to those with idiopathic
ASD. These results are discussed in relation to the wider behavioural phenotype and the emerging evidence of an
autism endophenotype in PMS.
Keywords: Phelan–McDermid syndrome, Autism spectrum disorder, SHANK3, Behavioural phenotype, Mood,
Repetitive behaviour, Impulsivity, Hyperactivity
Background
Phelan–McDermid syndrome (PMS) is a micro-deletion
syndrome with diagnosis based on cytogenetic, molecular
cytogenetic and/or molecular evidence of loss or disruption
at 22q13.3 [1]. The incidence of PMS is unknown, with
under-diagnosis suspected due to the subtlety of the dele-
tion [2]. Approximately 80% of people with PMS have de
novo, simple terminal deletions, and the remaining 20%
typically result from unbalanced translocations and ring
chromosomes [1]. The 22q13 region contains the SHANK3
gene: haploinsufficiency of SHANK3 is proposed to cause
the major features of PMS [3–5], and mutations in the
SHANK1, SHANK2 and SHANK3 genes are associated with
autism spectrum disorder [6]. Recent research has demon-
strated that the SHANK3 mutation results in neuronal
changes, including increase in input resistance to excitabil-
ity, some impairment in dendritic branching and decreases
in synaptic transmission [7]. These changes are mechanis-
tically linked to impairments in hyperpolarization-activated
cation (Ih) channels, with a suggestion that reduced Ih cur-
rents may account for some of the phenotypic characteris-
tics observed in PMS [7]. Dysmorphic physical features
associated with PMS are subtle and include hypotonia, nor-
mal to accelerated growth, long eye lashes, large ears, full
brow, dolicocephaly, full cheeks, bulbous nose and pointed
chin [1, 4, 8]. The most characteristic clinical features of
PMS are moderate to profound intellectual disability and
absent to severely delayed speech [1, 2, 8–10]. Preliminary
research suggests that the physical features and severity of
intellectual disability correlate with the size of the genetic
deletion. However, expressive speech deficits are not associ-
ated with the size or type of deletion [8].
A number of behavioural characteristics have been re-
ported in PMS. Hyperactivity, impulsivity and difficulties in
sustaining attention have been identified; 34% of children
with PMS were reported to have a diagnosis of attention
deficit hyperactivity disorder (ADHD) [11], 36% of children
scored above clinical cutoff for ADHD on a screening
measure [12] and a high proportion of parents endorsed
items indicative of impulsivity and inattention [11]. These
findings suggest a potential association between PMS and
ADHD phenomenology. However, few studies have
employed measures designed for individuals with intellec-
tual disabilities and none of the studies compared the
results for the PMS group to contrast groups. Thus, it is
unclear whether the presence of ADHD symptoms should
be attributed to the behavioural phenotype of PMS, the se-
verity of intellectual disability, age of the children assessed
or the measures used. Similar threats to validity weaken re-
sults associating atypical affect with the behavioural pheno-
type of PMS. Cohort and case studies identified behaviours
indicative of depression and psychosis/atypical bipolar dis-
order in PMS [11, 13]. However, given deficits in expressive
language, it is unclear how internal experiences of positive
symptoms of psychosis or depression have been reported
and assessed. Nonetheless, given the clinical implications of
mood disturbances, these findings warrant further investi-
gation, utilising robust measures validated for individuals
with intellectual disability and contrasting findings with ap-
propriate comparison groups.
A final characteristic, frequently identified in PMS, is that
of autism spectrum disorder (ASD) [2, 11, 12, 14] with a re-
cent review suggesting that all individuals diagnosed with
PMS should undergo specialist ASD assessments [15]. The
putative association between ASD and PMS is of particular
interest as the SHANK3 gene is one of the many implicated
in the aetiology of idiopathic ASD [3, 16, 17] with SHANK3
deficiency associated with 0.5 to 2% of cases of ASD and in-
tellectual disability [18]. Thus, delineation of the prevalence
and phenomenology of ASD in PMS may have clinical im-
plications for individuals with PMS and individuals with
idiopathic ASD. Results from screening instruments have
demonstrated convergent results: mean autism/pervasive
developmental disorders scale scores for children on the
Reiss Scales were above clinical cutoff [11]; 94% of children
with PMS scored in the mild to moderate range for ASD
and 67% in the severe range for ASD using the Childhood
Autism Rating Scale [2]; 85% of children with PMS met the
cutoff for ASD on the Social Communication Questionnaire
(SCQ) and 67% met the more stringent cutoff for autism
[12]. More robust evidence is found in studies employing
clinical diagnostic measures of ASD. Soorya and colleagues
[14] utilised both the Autism Diagnostic Observation
Schedule (ADOS) [19] and Autism Diagnostic Interview-
Revised (ADI-R) [20] and found that 84% of the sample
with PMS met criteria for ASD and 75% met criteria for the
more stringent classification of autistic disorder. However,
whilst there appears to be a strong association between
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ASD phenomenology and PMS, no studies have employed
contrast or comparison groups to evaluate whether ASD
phenomenology can be identified as a specific component
of the behavioural phenotype of PMS, rather than attributed
to the level of intellectual disability associated with the syn-
drome. This is particularly important given the potential for
over-estimating ASD when intellectual disability and ex-
pressive speech deficits are present [21].
Whilst there is a purportedly high prevalence of ASD
phenomenology in PMS, the profile of ASD impairments
in communication and social interaction and repetitive be-
haviour domains in the syndrome is less well described.
The profile of ASD is known to vary across genetic syn-
dromes [22]. For example, a recent meta-analysis demon-
strated that ASD phenomenology is common in Cornelia
de Lange and fragile X syndromes [23], and yet, detailed
item-level analysis of screening [24] and diagnostic mea-
sures [25] reveal that both syndromes evidence an atypical
profile of ASD. Philippe and colleagues [26] reported that
whilst children with PMS attained high ADI-R scores,
these only reached clinical thresholds in social interaction,
play, and communication domains. They argue that the
relative lack of repetitive behaviours distinguishes PMS
from idiopathic ASD. However, the study was limited by
not including an idiopathic ASD comparison group and
relying upon visual inspection of data. Additionally, a
number of sub-threshold items in the repetitive behaviour
domains necessitated expressive language (e.g. delayed
echolalia, verbal rituals). Interestingly, Soorya and col-
leagues [14] also found that interpretation of the ADI-R
algorithm alone indicated that many children with PMS
presented with sub-threshold levels of repetitive behav-
iour. However, when they included statistical analysis of
all items, including a two factor algorithm of repetitive be-
haviour identified in research on the ADI-R, they found
that repetitive and sensory-motor behaviours were present
in the majority of the participants, and were similar in
range to those reported in idiopathic ASD.
Finally, authors have suggested that behaviours indicative
of psychopathology (psychosis and low mood) may be mis-
interpreted as ASD phenomenology in individuals with
PMS [11]. Shaw and colleagues [11] report that some en-
dorsed items could indicate both ASD and mental health
problems, e.g. “Does not seem to listen when spoken to dir-
ectly”, “Random and inappropriate speech” and “Appears
confused”. Additionally, they suggest that other items such
as “Maintains a rigid posture”, “Appears to be in a stupor, as
if intoxicated” and “Laughs or appears angry for no appar-
ent reason” may be more indicative of psychosis than ASD.
However, it could be argued equally that these behaviours
are indicative of repetitive behaviour, sensory difficulties or
problems with emotional regulation, all of which are com-
monly reported in idiopathic ASD. Thus, there is a need to
evaluate further the profile of ASD in PMS, utilising
measures appropriate for individuals with intellectual dis-
ability, and with sufficient specificity and psychometric
properties to allow for item-level statistical analysis. Add-
itionally, these analyses need to be made in comparison to
contrast groups, necessarily including individuals with idio-
pathic ASD, and ideally including groups with other genetic
syndromes with known ASD profiles, in order to determine
the relative position of the ASD profile in PMS.
A final point of interest is that the investigation of the
profile of ASD impairments in PMS appears to have been
largely driven by the hypothesised genetic links between
PMS and idiopathic ASD. This has resulted in studies ana-
lysing the ASD profile of all participants in the PMS sam-
ples [11, 14, 26] in order to establish whether the profile
in the syndrome is similar to individuals with idiopathic
ASD. These data could support or weaken the hypothe-
sised genetic SHANK3 link. A complementary analysis ap-
proach would be to restrict analyses to those who score
above threshold for autism and ASD. These data would
answer a second question about whether individuals with
PMS meet criteria for autism for the same reasons as indi-
viduals with idiopathic ASD. Answers to this question
would inform discussion of the specific clinical needs for
individuals with PMS who evidence ASD behaviours, thus
increasing the specificity of clinical provision and inter-
ventions for individuals with PMS.
In summary, there is emerging evidence of attentional
differences and differences of mood in individuals with
PMS [11, 12]; however, these findings require further inves-
tigation utilising measures appropriate for individuals with
intellectual disabilities, allowing for statistical comparisons
with contrast groups. Additionally, there is evidence of a
heightened prevalence of ASD phenomenology in PMS [2,
11, 12, 14]. The prevalence and profile of these ASD behav-
iours require further investigation with particular attention
to the profile of repetitive behaviours in the syndrome.
There is a need to delineate the profile of ASD phenomen-
ology in PMS in contrast to individuals with idiopathic
ASD, and individuals with genetic syndromes with known
ASD profiles. Fragile X and Down syndromes may provide
useful comparisons as they evidence divergent prevalence
of ASD phenomenology (~ 30% in males with fragile X syn-
drome, ~ 16% in Down syndrome [23]) and well-known
profiles of ASD behaviour. Contrasts between PMS and fra-
gile X and Down syndromes will facilitate exploration of
whether ASD phenomenology can be attributed to the be-
havioural phenotype of PMS, over and above the level of in-
tellectual disability associated with presence of the
syndrome. Comparisons between PMS and an idiopathic
ASD contrast group will allow evaluation of whether the
profile of impairments in PMS is commensurate to those
seen in idiopathic ASD. Finally, given tentative hypotheses
regarding diagnostic overlap between ASD phenomenology
and mental health problems [11], an evaluation of the
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associations between ASD phenomenology and the broader
behavioural phenotype in PMS may prove useful. There-
fore, this study has the following aims:
i) To describe the behavioural phenotype of PMS,
specifically the profile of overactivity/impulsivity,
mood and repetitive behaviour. This will be achieved
by comparing a sample with PMS to matched
comparison groups with fragile X syndrome, Down
syndrome and idiopathic ASD.
ii) To delineate the prevalence of ASD behaviours, as
measured by an ASD screening tool, in PMS in
comparison to matched samples with fragile X
syndrome, Down syndrome and idiopathic ASD.
iii)To delineate the profile of ASD phenomenology in
PMS, through analysis of subscales and items on the
ASD screening tool, in comparison to matched
samples with fragile X syndrome, Down syndrome
and idiopathic ASD.
iv) To investigate whether individuals with PMS attain
scores above the threshold for ASD on an ASD
screening measure for the same reasons as matched
individuals with idiopathic ASD.
v) To investigate associations between scores on the
ASD screening measure and the profile of repetitive
behaviour, impulsivity/overactivity and mood in
individuals with PMS, compared to the matched
samples with fragile X syndrome, Down syndrome
and idiopathic ASD.
Methods
Recruitment
Participants with PMS were contacted via UNIQUE, the
UK syndrome support group for rare genetic disorders,
and were invited to participate in the study. Eighty-five
parents and carers were contacted, and 36 completed
and returned the questionnaires (return rate 42%).
Participants for the comparison groups with idiopathic
ASD, fragile X syndrome and Down syndrome were re-
cruited via the National Autistic Society, Fragile X Soci-
ety and the Down’s Syndrome Association respectively.
Two hundred eighty-eight carers of individuals with
ASD (return rate 19.63%), 144 carers of individuals with
Down syndrome (return rate 28.80%) and 212 carers of
boys with fragile X syndrome (return rate 44%) com-
pleted the questionnaire pack.
Procedure
All carers received an information sheet, cover letter,
consent form, demographic questionnaire and ques-
tionnaire pack. To avoid priming, the study was de-
scribed as “Understanding behaviour in people with
neurodevelopmental disorders”. Carers returned the
completed questionnaires and consent forms in a
prepaid envelope. Ethical approval for this study was
obtained from Coventry NHS Ethics Committee.
Participants
Participants from all groups were excluded from the
study if (1) they were under the age of four, as some
measures were not appropriate for young children, (2)
25% or more of the data was missing or incomplete or
(3) they did not have a confirmed diagnosis of the re-
spective syndrome from an appropriate professional. For
individuals with PMS, fragile X syndrome and Down
syndrome, the diagnosis professionals included general
practitioners, clinical geneticist, paediatricians and neu-
rologists. For individuals with ASD, the professionals
additionally included psychiatrists, clinical psychologists
and educational psychologists.
Exclusions based on the above criteria resulted in a
total of 30 participants with PMS. Twenty-one (70%) of
the participants with PMS were diagnosed by a clinical
geneticist and eight (27%) by a paediatrician. For the
remaining individual with PMS (3%), diagnosis was con-
firmed by fluorescence in situ hybridization test.
Matched groups with ASD, fragile X syndrome and
Down syndrome were then selected from the comparison
samples. These groups were matched on chronological
age (± 3 years) and self-help score (± 3) derived from the
Wessex Scale [27]. Self-help scores were utilised as a
proxy measures of degree of disability. Sixteen (53%) of
the participants with fragile X syndrome were diagnosed
by a paediatrician, thirteen (43%) by a clinical geneticist
and one by a consultant psychiatrist. Twenty-five (83%) of
the participants with Down syndrome were diagnosed by
a paediatrician, one by a general practitioner (3%) and four
by other professionals including during ante-natal screen-
ing (13%). Sixteen of the participants with ASD were diag-
nosed by a paediatrician (53%), five by a general
practitioner (17%), four by a psychiatrist (13%), three by a
clinical psychologist (10%), one by an educational psych-
ologist (3%) and one by a clinical geneticist (3%).
Table 1 presents the demographic characteristics of
the groups. The mean age of the total sample was
10.80 years (SD = 7.06; range = 4–39 years), 83 (69.2%)
were male and 60 (50.0%) were able/partly able (score
above six on the self-help subscale of the Wessex Scale).
Ninety-one (75.8%) were mobile, 89 (74.2%) verbal, 100
(83.3%) had normal hearing and 94 (78.3%) had normal
vision. After matching, significant differences were still
found between the groups for gender (accounted for by
the fact that only males with fragile X syndrome were
recruited), self-help score, hearing and speech.
Idiopathic ASD comparison group
To confirm the validity of the idiopathic ASD comparison
sample as a reference group, SCQ data were compared to
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that of the normative sample reported in the SCQ manual
[28, 29]. This method for validating an ASD reference
group has been utilised previously in a study investigating
the profile of autism phenomenology in genetic syn-
dromes [24]. The manual reports the percentage of indi-
viduals in the SCQ normative sample who displayed
“impairments” for each item. Data were extracted based
on calculations from these percentages and the total sam-
ple size. These data were then used to calculate odds ra-
tios at item level, using 99% confidence intervals. Odds
ratio analyses revealed no significant differences between
the idiopathic ASD comparison sample in the present
study and the normative SCQ sample on 34 of 39 items.
The idiopathic ASD comparison group in the present
study was more likely to score as “impaired” on four SCQ
items including three algorithm items: social chat, neolo-
gisms and unusual sensory interests, and one non-
algorithm item: unusual attachments to objects. The
idiopathic ASD comparison sample in the present study
was less likely to score as “impaired” on seeking to share
enjoyment. Overall, these findings validate the matched
sample selected in this study, demonstrating that they are
very similar to the normative sample reported in the SCQ.
Measures
The questionnaire pack included the following informant-
based questionnaire measures which are all appropriate
for children and adults with intellectual disabilities. The
order of the measures in the questionnaire pack was coun-
terbalanced across the group to reduce order effects.
A demographic questionnaire that required information
on date of birth, gender, mobility, verbal ability and diagno-
sis was included. The Wessex [27] was used to assess ability
as a proxy IQ measure. This measure was selected as in
samples of individuals with ASD and intellectual disability,
adaptive functioning and IQ scores are well correlated and
IQ is a significant predictor of adaptive functioning [30–
32]. The Wessex comprises five subscales including contin-
ence, mobility, self-help skills, speech and literacy. For this
study, the self-help subscale was used to estimate degree of
ability and responses to items on mobility and vision and
hearing were used to further describe the groups. The Wes-
sex Scale has a modest inter-rater reliability at subscale
level for both children and adults (mean kappa value of .62
and .54 for overall classification and item level reliability re-
spectively; [27, 33]). The Wessex is an effective tool for
large-scale questionnaire studies [33].
The Mood, Interest and Pleasure Questionnaire-Short
form (MIPQ-S) [34] was used to assess mood and com-
prises 12 items, forming two subscales: Mood and Interest
and Pleasure. The measure has good internal consistency
(Cronbach’s alpha coefficients: total = .88, Mood = .79,
Interest and Pleasure = .87), test-retest (.97) and inter-
rater reliability (.85). Internal consistency for subscales is
good (alpha coefficient range for subscales .84–.94). Con-
current validity between the MIPQ and the Aberrant Be-
havior Checklists (ABC) ranged from medium to strong
(0.36–0.73; p < .001).
The Activity Questionnaire (TAQ) [35] was included
to assess behaviours indicative of overactivity and impul-
sivity. The measure has 18 items which form three sub-
scales of Overactivity, Impulsivity and Impulsive Speech.
Item-level inter-rater reliability ranges from .31 to .75
(mean .56), and test-retest reliability ranges from .60 to
.90 (mean .75). Inter-rater and test-retest reliability indi-
ces for subscales and total score exceed .70. Internal
Table 1 Mean age (standard deviation) and range, percentage of males, mean self-help score (standard deviation) and percentage
of participants who were mobile, verbal, had normal hearing and normal vision for all groups
Syndrome group Chi-square Post hoc < .01
PMS ASD FraX DS df χ2 p value
N 30 30 30 30
Agea Mean (SD) 10.55 (7.08) 10.60 (7.46) 11.37 (7.02) 10.67 (7.00) 3 1.29* .732 –
Range 4.00–37.00 4.00–39.00 6.00–39.00 4.00–36.00
Gender Male (%) 13 (43.33) 26 (86.67) 30 (100.00) 14 (46.67) 3 34.19 < .01 ASD, FraX > PMS, DS
Self-helpb Mean (SD) 4.77 (1.14) 5.33 (1.24) 5.33 (1.09) 6.20 (1.06) 3 20.47* < .001 DS > PMS, ASD, FraX
Mobilityb Fully mobile (%) 22 (73.33) 23 (76.67) 20 (66.67) 26 (86.67) 3 34.10 .33 –
Visionb Normal (%) 24 (80.00) 27 (90.0) 24 (80.0) 19 (63.33) 3 6.89 .08 –
Hearingb Normal (%) 26 (86.67) 27 (90.00) 29 (96.67) 18 (60.00) 3 15.23** .001 PMS, ASD, FraX > DS
Speechc Verbal (%) 5 (16.77) 20 (66.77) 24 (80.00) 24 (80.00) 3 33.96 < .001 ASD, DS, FraX > PMS
Significant differences are highlighted in italics
Groups: PMS Phelan–McDermid syndrome, ASD autism spectrum disorder, FraX fragile X syndrome, DS Down syndrome
*Kruskal–Wallis test for continuous non-normally distributed data
**Fisher’s exact test calculated
aIn years (decimal)
bData derived from the Wessex Scale
cAccording to item 1 on the SCQ “Is he/she now able to talk using short phrases or sentences”
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consistency for the subscales is good (alpha coefficient
range for subscales .67–.94).
The Repetitive Behaviour Questionnaire (RBQ) [36] was
used to assess repetitive behaviours and comprises five
subscales: Stereotyped behaviour, Compulsive behaviour,
Insistence on Sameness, Restricted Preferences and Re-
petitive Speech. Previous examination of the psychometric
properties of the RBQ [36] reveals good inter-rater reli-
ability coefficients (range .46–.80), test-retest reliability
(range .61–.93; [36]) and internal consistency (alpha coef-
ficient range for subscales .50–.78). Concurrent validity
and content validity between the RBQ and the repetitive
behaviour subscale of the ASQ is good (0.6; p < .001).
The Social Communication Questionnaire—Lifetime
version [28] was included to assess ASD behaviours. The
SCQ was developed as a tool for screening for ASD in
children and adults and is based on the ADI-R [20]. The
measure consists of 40 items which are scored to indi-
cate the presence (a score of 1) or absence (a score of 0)
of autistic impairments. These items are grouped into
three subscales which correspond to impairments in
communication, social interaction and repetitive and ste-
reotyped patterns of behaviours. The authors identify a
cutoff score of 15 as indicative of autistic spectrum dis-
order and a higher cutoff of 22 to differentiate between
individuals with autism and those with other pervasive
developmental disorders. The SCQ shows good concur-
rent validity with the ADI-R and the ADOS [37]. Im-
portantly, the SCQ demonstrates higher precision in
samples with low IQ than other screening tools, includ-
ing the Children’s Communication Checklist and the
Social Responsiveness Scale [38]. Internal consistency is
also good (α = .90 for the total scale). The SCQ has good
item-level validity, with 33 out of 39 items differentiating
between those with ASD and those without ASD [29].
The fragile X and Down syndrome groups completed an
earlier version of the SCQ (Autism Screening Question-
naire (ASQ)). One item differed between the ASQ and
SCQ for non-verbal individuals for subscale scoring
(item 20, social chat). Following the approach taken by
Moss and colleagues [24] to ensure consistency across
the groups, this item was treated as missing and pro-
rated for all non-verbal participants. The prorated score
was calculated as the mean item score, based on other
completed items within the communication domain.
Item 20 was not included in the item-level analysis.
Data analysis
Data were tested for normality using Kolmogorov–Smir-
nov tests. Where data were not normally distributed
(p < .05), non-parametric techniques were employed. To
control for multiple comparisons, alpha levels were set
at a conservative value of p < .01.
Results
Behavioural phenotype of PMS
In order to fulfil the first aim of the study, delineating
the behavioural phenotype of PMS, compared to the
matched contrast groups, subscale scores were derived
to describe mood (taken from the MIPQ), activity levels
(taken from the TAQ) and repetitive behaviour (taken
from the RBQ). A series of Kruskal–Wallis tests were
performed to test for differences in the subscales be-
tween the groups. Table 2 displays the subscale, total
scores and Kruskal–Wallis statistics.
The results in Table 2 reveal that individuals with PMS
had significantly higher total mood scores than individuals
with idiopathic ASD,1 although they also demonstrated
significantly lower total mood scores than individuals with
Down syndrome. The PMS group evidenced significantly
higher levels of stereotyped behaviour than individuals
with Down syndrome. However, they also had significantly
lower scores for compulsive behaviour than the idiopathic
ASD group. Additionally, individuals with PMS obtained
significantly lower scores for insistence on sameness and
total repetitive behaviour than both the fragile X and idio-
pathic ASD groups. Individuals with PMS did not differ
from individuals with idiopathic ASD, fragile X or Down
syndrome on measures of activity level.
In summary, individuals with PMS evidenced higher
mood, but lower levels of repetitive behaviour than those
with idiopathic ASD. The PMS group had lower mood
scores than those with Down syndrome. The activity
levels in individuals with PMS did not differ to those
identified in any of the contrast groups.
Prevalence of ASD phenomenology in PMS
In order to investigate the second aim of the study, to
delineate the prevalence of ASD behaviours in PMS in
comparison to the contrast groups, the percentage of
each group scoring above the cutoff for ASD (score ≥
15) and autism (score ≥ 22) were derived from the SCQ.
These prevalence data were compared between groups
using chi-square tests. Table 3 displays the results.
The results revealed that 86.7% of individuals with
PMS scored above the threshold for ASD and 56.7%
scored above the threshold for autism. There was a sig-
nificant difference between the proportion of individuals
in each group scoring above the cutoff for ASD (χ2
(3) = 51.38, p < .001; ASD, FraX, PMS > DS). There was
also a significant difference between the proportion of
individuals in each group scoring above the cutoff for
autism (χ2 (3) = 17.17, p = .001; ASD, FraX, PMS > DS).
In summary, the proportion of individuals with PMS
who scored above the SCQ thresholds for ASD and aut-
ism was higher than those in the Down syndrome group,
but did not differ from those with idiopathic ASD or fra-
gile X syndrome.
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Profile of ASD phenomenology in PMS
In order to investigate the third aim of the study, to de-
lineate the profile of ASD phenomenology in PMS, sub-
scale scores for Communication, Repetitive Behaviour
and Reciprocal Social Interaction domains were derived
from the SCQ for the PMS group and the matched com-
parison groups. In order to allow for the high proportion
of individuals with PMS who were non-verbal, subscale
scores excluding verbal items were generated and differ-
ences between the groups were evaluated using Krus-
kal–Wallis tests. These subscale and total scores are
presented in Table 4 with Kruskal–Wallis test results to
evaluate differences between the groups.
The results in Table 4 reveal that the PMS group
showed significantly more “ASD-like” communication
impairments than the Down syndrome group, but did
not differ from any of the groups in repetitive behav-
iours. The PMS group evidenced significantly more
“ASD-like” reciprocal social interaction impairments
than individuals with Down syndrome. At total score
level, the PMS group were significantly more impaired
than those with Down syndrome.
In order to further evaluate the profile of ASD phe-
nomenology in PMS, the percentage of individuals in
each group scoring as “impaired” (score of 1) for each
non-verbal item of the SCQ was calculated. Differences
between the groups for each item were evaluated using
chi-square tests. Table 5 presents the results.
The results revealed that significantly more of the
PMS group than the Down syndrome group scored as
impaired on five of the seven items in the Communica-
tion subscale. Additionally, for the item describing “nod-
ding to say no”, significantly more individuals with PMS
were identified as impaired than individuals with fragile
X syndrome and Down syndrome. Significantly more of
the PMS group than the Down syndrome group scored
Table 2 MIPQ, RBQ and TAQ subscale/total score medians and interquartile ranges (excluding verbal subscales)
Measure Median scores (interquartile range) Kruskal–Wallis test Post hoc < .01
PMS FraX DS Idiopathic ASD df K p valuea
MIPQ-S
Mood 20.00
(17.75–21.25)
21.00
(19.75–21.18)
22.00
(19.75–22.25)
17.00
(16.00–21.00)
3 22.26 < .001 FraX, DS > ASD
Interest and Pleasure 16.00
(12.88–20.00)
18.00
(13.00–19.25)
20.00
(17.75–22.00)
12.00
(8.75–15.25)
3 27.53 < .001 DS > ASD
Total score 36.00
(31.75–41.00)
39.00
(31.75–42.00)
41.00
(38.75–44.00)
29.50
(25.00–35.25)
3 30.34 < .001 PMS, DS, FraX > ASD,
DS > PMS
RBQ
Stereotyped behaviour 7.50
(5.75–12.00)
9.00
(7.37–12.00)
0.50
(0.00–6.50)
9.50
(6.00–12.00)
3 24.84 < .001 PMS, ASD, FraX > DS
Compulsive behaviour 0.00
(0.00–4.50)
6.00
(0.00–9.00)
0.00
(0.00–3.25)
6.00
(3.50–15.25)
3 21.81 < .001 ASD > DS, PMS
Insistence on sameness 0.00
(0.00–2.50)
4.00
(3.00–7.25)
0.00
(0.00–2.25)
4.00
(2.00–6.00)
3 30.45 < .001 ASD, FRaX > DS, PMS
Total score 12.00
(7.75–19.75)
29.50
(22.50–36.25)
10.50
(4.00–15.25)
25.00
(16.00–32.50)
3 39.44 < .001 ASD, FRaX > DS, PMS
TAQ
Impulsivity 16.50
(12.00–20.25)
20.72
(15.75–23.25)
12.00
(7.75–18.25)
20.00
(16.50–23.00)
3 18.22 < .001 ASD, FraX > DS
Overactivity 19.00
(12.75–25.25)
24.00
(12.75–32)
9.50
(6.00–23.25)
20.50
(15.75–30.00)
3 14.54 .002 ASD, FraX > DS
Total score 37.00
(26.50–45.25)
48.50
(32.00–59.25)
23.00
(17.00–41.75)
50.00
(33.25–53.75)
3 17.45 .001 ASD, FraX > DS
aSignificant differences (p < .01) are indicated in italics
Table 3 Percentage scoring above the ASD and autism cutoffs
on the SCQ
Group % scoring above
ASD cutoff
(N)
% scoring above
autism cutoff
(N)
PMS 86.7
(26)
56.7
(17)
FraX 80.0
(24)
51.9
(14)
DS 23.3
(7)
22.2
(6)
Idiopathic ASD 100.0
(30)
76.7
(23)
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as impaired on four of the seven items in the Repetitive
Behaviour subscale. However, significantly fewer individ-
uals with PMS were identified as showing ritualistic re-
petitive behaviours, relative to individuals with
idiopathic ASD and fragile X syndrome. Significantly
more of the PMS group than the Down syndrome group
scored as impaired on eight of the 15 items in the Recip-
rocal Social Interaction subscale. Importantly, signifi-
cantly more individuals with PMS showed impairments
in “showing and directing attention” than individuals
with idiopathic ASD or Down syndrome. Conversely,
significantly fewer individuals with PMS showed impair-
ments in items regarding interest in other children, and
responding to other children’s approaches, than individ-
uals with idiopathic ASD.
In summary, the PMS group did not differ from the
idiopathic ASD or fragile X syndrome groups in levels of
“ASD-like” communication impairments. When verbal
items were removed, they evidenced significantly more
communication impairments than those with Down syn-
drome. At the item level, individuals with PMS evi-
denced specific impairments in using nodding to
communicate with others. The PMS group did not differ
from the fragile X or Down syndrome groups in levels of
“ASD-like” repetitive behaviour but did evidence signifi-
cantly less impairment than the idiopathic ASD group
when verbal items were included in analysis. At the item
level, the PMS group demonstrated significantly less
ritualistic behaviour. The PMS group evidenced signifi-
cantly more impairment in social interaction than the
Down syndrome group and did not differ from the idio-
pathic ASD or fragile X syndrome groups. At the item
level, those with PMS evidenced significant impairment
in showing and directing attention, but relative preserva-
tion of interest in, and responses to, other children com-
pared to those with idiopathic ASD.
Analysis of items associated with meeting threshold for
autism in PMS
In order to meet the fourth aim of the study, to explore
whether individuals with PMS reach threshold on the
SCQ for similar reasons as individuals with idiopathic
ASD, item-level comparisons were conducted, compar-
ing those with PMS who scored over the threshold for
autism (≥ 22) to those with idiopathic ASD who also
scored over the threshold for autism. The number of in-
dividuals in the PMS group scoring as “impaired” on
each item was compared to the number of individuals in
the idiopathic ASD comparison group scoring as im-
paired on each item, using relative risk ratios with 99%
confidence intervals.
The results in Fig. 1 reveal that individuals with PMS
who met criteria for autism on the SCQ were no more
or less likely to evidence impairments in the Communi-
cation items than individuals with idiopathic ASD. How-
ever, they were significantly more likely to score as
impaired on the “Showing and directing attention” item
in the Reciprocal Social Interaction domain and signifi-
cantly less likely to score as impaired on the “Rituals”
item in the Repetitive Behaviour domain.
Association between behavioural phenotype and ASD
phenomenology in PMS
In order to fulfil the final aim of the study, to investigate
the association between ASD phenomenology and be-
havioural phenotype, a series of Spearman’s rank correla-
tions were conducted for each group, evaluating
associations between total SCQ score and demographic
characteristics (self-help score and chronological age)
and behavioural characteristics (mood, activity and re-
petitive behaviour).
Table 6 reveals that higher scores on the SCQ were
significantly correlated with lower scores on the interest
and pleasure subscale for individuals with PMS. The cor-
relation between SCQ score and mood score approached
significance (rs (28) = − .37, p = .043).
Discussion
The behavioural characteristics, prevalence and profile
of ASD phenomenology in PMS were delineated in
this study. The association between ASD phenomen-
ology and broader behavioural and demographic
Table 4 SCQ subscale/total score medians and interquartile ranges, calculated with and without verbal items
Domain Median scores all items (interquartile range) Kruskal–Wallis test Post hoc < .01
PMS FraX DS Idiopathic ASD df k p valuea
Communication (verbal items removed) 7.00
(4.00–7.00)
4.00
(3.00–5.80)
1.00
(0.00–4.00)
6.00
(4.00–7.00)
3 29.97 < .001 ASD, PMS > DS
Repetitive Behaviour (verbal items removed) 4.00
(2.75–5.00)
5.00
(3.00–6.00)
1.00
(0.00–4.00)
5.50
(4.00–7.00)
3 32.72 < .001 ASD, FraX > DS
Reciprocal Social Interaction 10.00
(7.75–13.00)
9.00
(6.00–11.00)
3.00
(1.00–8.00)
11.25
(9.00–13.00)
3 28.04 < .001 ASD, PMS > DS
Total score (verbal items removed) 21.50
(18.75–25.00)
18.50
(12.00–23.25)
5.00
(2.00–12.50)
23.40
(19.00–27.00)
3 35.66 < .001 ASD, PMS > DS
aSignificant differences (p < .01) are indicated in italics
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characteristics was also evaluated. The novel recruit-
ment of comparison groups with fragile X and Down
syndrome, in which the profile of ASD phenomen-
ology is well described, strengthens the validity of the
study. The inclusion of a matched idiopathic ASD
comparison group allows for robust delineation of the
profile of ASD phenomenology in PMS. The use of
validated measures, with appropriate psychometric
properties established in populations with intellectual
disabilities further contributes to the validity and reli-
ability of the findings.
The results of the behavioural phenotype analyses re-
vealed that individuals with PMS evidenced higher total
mood scores than those with idiopathic ASD, but lower
total mood scores than those with Down syndrome. Des-
pite the between group differences identified at the total
score level, there were no identified differences on the
Mood or Interest and Pleasure subscales between the
PMS and comparison groups. These findings support
previous research identifying low mood in individuals
with PMS [11], but also demonstrate the utility of in-
cluding multiple comparison groups in order to position
Table 5 Percentage of individuals that scored as “impaired” on SCQ non-verbal algorithm items
% impairment Chi-square
Domain Item PMS FraX DS ASD df χ2 p valuea Post hoc < .01
Communication Imitation 76.7 46.7 33.3 83.3 3 15.53 .001 ASD > FraX, DS; PMS > DS +b
Pointing 86.7 56.7 33.3 70.0 3 15.87 .001 PMS > DS +
Gestures 70.0 46.7 36.7 60.0 3 5.53 .137 N/A N/A
Nodding to mean yes 86.7 46.7 23.3 83.3 3 31.50 < .001 ASD, PMS > FraX, DS + +
Head shaking to mean no 73.3 36.7 23.3 76.7 3 21.22 < .001 ASD > FraX, DS; PMS > DS +
Imitative social play 80.0 60.0 16.7 76.7 3 28.22 < .001 ASD, PMS, FraX > DS +
Imaginative play 83.3 80.0 36.7 80.0 3 21.05 < .001 ASD, PMS, FraX > DS +
Repetitive Behaviour Rituals 40.0 73.3 46.7 83.3 3 17.18 .001 ASD > PMS, DS; FraX >
PMS
−
−c
Unusual preoccupations 60.0 63.3 20.0 70.0 3 19.44 < .001 ASD, PMS, FraX > DS +
Stereotyped play 66.7 60.0 30.0 76.7 3 13.97 .003 ASD, PMS > DS +
Circumscribed interests 30.0 56.7 36.7 60.0 3 7.40 .060 N/A N/A
Sensory interests 53.3 43.3 13.3 83.3 3 29.15 < .001 ASD > FRaX, DS; PMS > DS +
Hand stereotypies 70.0 86.7 33.3 90.0 3 27.40 < .001 ASD, PMS, FRaX > DS +
Body stereotypies 56.7 60.0 23.3 66.7 3 12.64 .005 ASD, FraX > DS N/A
Reciprocal Social
Interaction
Inappropriate facial expressions 40.0 23.3 6.7 40.0 3 11.49 .009 ASD, PMS > DS +
Use of other’s body to communicate 83.3 56.7 40.0 86.7 3 20.10 < .001 ASD, PMS > DS +
Friends 70.0 80.0 30.0 76.7 3 19.72 < .001 ASD, PMS, FRaX > DS +
Eye contact 56.7 53.3 23.3 56.7 3 8.57 .036 N/A N/A
Social smiling 40.0 36.7 16.7 66.7 3 13.66 .003 ASD > DS N/A
Showing and directing attention 70.0 46.7 16.7 36.7 3 15.69 .001 PMS > ASD, DS + +
Offering to share 80.0 63.3 33.3 76.7 3 15.41 .001 ASD, PMS > DS +
Seeking to share enjoyment 43.3 26.7 23.3 36.7 3 2.27 .519 N/A N/A
Offering comfort 83.3 56.7 20.0 86.7 3 32.27 < .001 ASD, PMS, FraX > DS +
Quality of social overtures 56.7 26.7 13.3 46.7 3 12.67 .005 ASD, PMS > DS +
Range of facial expression 63.3 56.7 23.3 80.0 3 17.82 < .001 ASD, PMS, FRaX > DS +
Interest in children 60.0 56.7 26.7 90.0 3 21.91 < .001 ASD > PMS, DS –
Response to other children’s
approaches
53.3 63.3 23.3 86.7 3 23.64 < .001 ASD > PMS, DS; FraX > DS –
Imaginative play with peers 90.0 86.7 60.0 100.0 3 14.12d .001 ASD > DS N/A
Group play 86.7 73.3 46.7 86.7 3 12.64 .005 ASD, PMS > DS +
aSignificant differences are highlighted in italics (p < .01)
b“+” indicates that significantly more individuals in the PMS group scored as impaired one of the comparison groups
c“−” indicates significantly fewer individuals in the PMS group scored as impaired than one of the comparison groups
dFisher’s exact test calculated
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Fig. 1 Relative risk ratios comparing the PMS and idiopathic ASD groups on SCQ items in domain algorithms. Odds ratios with 99% confidence
intervals for SCQ items comparing individuals with PMS who score over the autism threshold to the idiopathic ASD group. The asterisk indicates
significant difference. The Y-axis scales differ between subscales
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the behavioural phenotype in PMS relative to other syn-
dromes. The PMS group achieved higher total mood
scores than those with idiopathic ASD and comparable
total mood scores to those with fragile X syndrome, sug-
gesting that whilst lower mood is present in PMS, it may
not be significantly atypical, given the degree of intellec-
tual disability in the group.
The use of a carefully designed and detailed assess-
ment of repetitive behaviour [36] revealed a mixed pro-
file in individuals with PMS. The group evidenced
similar levels of stereotyped behaviour, but lower levels
of compulsive behaviour, insistence on sameness and
total repetitive behaviour than both the fragile X syn-
drome and idiopathic ASD groups. This finding supports
and synthesises divergent results demonstrating low
levels of repetitive behaviour in PMS [26] and the pres-
ence of repetitive and sensory-motor behaviours in the
group [14]. Individuals with PMS appear to evidence a
dissociation between motor-driven repetitive behaviours,
which are common in the sample, and more compulsive
and routine-driven behaviours, which are less evident in
the group. It is important to note that this finding is at
the level of the total sample, including those who meet
threshold for autism and those who do not. Finally, the
results revealed no significant differences in levels of
overactivity or impulsivity between the PMS and com-
parison groups. This finding differs from those previ-
ously reported, where high levels of ADHD-type
behaviours were identified [11, 12]. However, previous
research did not compare individuals with PMS to
matched comparison groups, and thus, the high levels of
activity and impulsivity may be more appropriately asso-
ciated with the degree of intellectual disability in PMS
rather than the behavioural phenotype of PMS per se.
The results demonstrated a high prevalence of ASD
phenomenology in PMS, with 87% meeting threshold for
ASD and 57% meeting the more stringent criteria for
autism. These findings support the prevalence figures
identified in previous studies using screening measures
(94% mild–moderate ASD, 67% severe ASD [2]; 85%
ASD, 67% autism [12]) and diagnostic tools (84% ASD,
75% autistic disorder [14]). The results of this study ex-
tend findings by demonstrating that a similar proportion
of individuals with PMS meet threshold for ASD and
autism as males with fragile X syndrome, in whom ASD
phenomenology is common. Importantly, the proportion
of individuals in the PMS group meeting clinical thresh-
olds on the SCQ was significantly higher than the Down
syndrome group, suggesting that a high prevalence of
ASD phenomenology can be associated with the behav-
ioural phenotype of PMS. It is important to note that
whilst this study has demonstrated a high prevalence of
ASD phenomenology in PMS, this does not directly
equate to a high prevalence of ASD diagnoses in PMS,
given the necessity of thorough, multimodal assessment
in the clinical diagnoses of ASD.
Analyses to evaluate the profile of ASD phenomen-
ology in the total PMS sample provided heterogeneous
results across impairments in communication, social
interaction and repetitive and restricted behaviour.
Firstly, at subscale level, the group did not differ from
the idiopathic ASD or fragile X syndrome groups in
“ASD-like” communication impairments. Additionally,
the PMS group evidenced more impairments than those
with Down syndrome. This finding supports previous re-
sults highlighting “ASD-like” impairments in communi-
cation in PMS [14, 26]. Item-level analyses extended
these findings to reveal that the PMS group evidenced
specific impairments in “nodding to communicate yes”,
with a higher proportion of the PMS sample scoring as
impaired on this item than all three comparison groups,
although this did not reach statistical significance when
compared to the idiopathic ASD group who scored over
the autism threshold. The PMS group did not signifi-
cantly differ from the idiopathic ASD group on any item
in the communication domain, suggesting that the
Table 6 Correlation coefficients for Spearman’s rank correlations between total SCQ score and demographic/behavioural
characteristics
Demographic/behavioural characteristic PMS FraX DS Idiopathic ASD
Self-help − 0.20 − 0.07 − 0.21 − 0.02
Age 0.35 0.28 0.24 − 0.11
Mood − 0.28 − 0.06 0.07 − 0.40
Interest and pleasure − 0.50a − 0.20 − 0.38 − 0.14
Stereotyped behaviour 0.36 0.34 0.63 0.12
Compulsive behaviour − 0.08 − 0.21 0.22 0.39
Insistence on sameness − 0.04 − 0.32 0.13 0.04
Impulsivity 0.21 0.22 0.32 0.25
Overactivity 0.32 0.25 0.19 0.23
aSignificant correlations (p < .01) are highlighted in italics
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profile of “ASD-like” communication impairments is
similar in that of total PMS and idiopathic ASD groups.
Secondly, the PMS group did not differ from the idio-
pathic ASD, fragile X or Down syndrome groups in
“ASD-like” repetitive behaviours. However, item-level
analysis revealed that the PMS group was significantly
less likely to engage in non-verbal ritualistic behaviours
than those with fragile X syndrome or idiopathic ASD.
This difference remained significant in the secondary
analysis of individuals with PMS who scored above the
clinical threshold for autism. Thus, the profile of repeti-
tive behaviour is still somewhat unclear in PMS. Fine-
grained observational analysis of repetitive behaviours
would be beneficial, in order to detail topography, fre-
quency and any potential management difficulties of re-
petitive behaviour in the syndrome.
Finally, at the subscale level, the PMS group evidenced
significantly more impairments in social interaction than
the Down syndrome group and showed comparable
levels of impairment to the idiopathic ASD and fragile X
syndrome groups. This finding supports data demon-
strating “ASD-like” social interaction impairments in
PMS [14, 26]. An interesting dissociation in social inter-
action was revealed at item level; the PMS group showed
significantly more impairments in “Showing and direct-
ing attention” than both the Down syndrome and idio-
pathic ASD groups, but significantly less impairment in
items assessing interest in, and responses to, other chil-
dren. One interpretation of this finding is that there is a
divergence in social skills and social motivation in PMS,
with relatively preserved social motivation in contrast to
deficits in social competence, potentially due to low
levels of expressive speech. Alternatively, the result may
represent a specific impairment in initiating interaction,
with relatively preserved abilities to respond to interac-
tions initiated by others. This finding warrants further
investigation, including attempts to replicate the results
in larger samples with PMS, using both indirect and dir-
ect assessments of social competence and motivation.
Whilst the profile of ASD impairments was varied
within the total PMS sample, the results within the sub-
group that scored above the autism threshold were very
similar to the profile of behaviour in the idiopathic ASD
group, suggesting that both groups reach clinical thresh-
olds for autism due to a similar profile of behaviours.
The results in this subgroup revealed that individuals
with PMS were neither more nor less likely to score on
items in the communication, social interaction or repeti-
tive behaviour domain, than those with idiopathic ASD
except for an increased impairment in “Showing and
directing attention” and a decreased likelihood of ritual-
istic behaviour. This finding extends previous research,
affording a more refined understanding of the nature
ASD impairments in affected individuals with PMS. The
result suggests that when individuals with PMS meet cri-
teria for autism, they do so for similar reasons to those
with idiopathic ASD. Clinically, this may indicate that
interventions to support individuals with idiopathic ASD
could be usefully applied to individuals with PMS who
meet the diagnostic criteria. The result also replicates
the specific deficit noted in the total sample in showing
and directing attention. Interventions to extend the be-
havioural repertoires of individuals with PMS focused on
behaviour to recruit and maintain others’ attention
which may be warranted in this population.
The final results of this study demonstrated that across
all demographic and behavioural scores, only “Interest
and pleasure” was (negatively) correlated with SCQ
score in the PMS group. The correlation between
“Mood” and total SCQ score approached significance.
These findings lend tangential support to previous re-
search indicating an association between the presenta-
tion of mood disorders and ASD phenomenology in the
syndrome [11]. However, given the strength of evidence
of behaviours indicative of ASD in PMS, the correlation
between interest and pleasure and SCQ score is not
interpreted as substantiation of mood disorders being
wholly explanatory for ASD phenomenology in PMS. In-
stead, it is possible that behaviours indicative of low
mood are associated with ASD impairments in PMS. Al-
ternatively, it may be that mood disorders and ASD im-
pairments co-exist within PMS due to similar genetic
underpinnings, perhaps with greater severity of mood
disorder being associated with more significant genetic
deletion, as ASD phenomenology is hypothesised to [8].
These hypotheses are tentative and further research is
required to delineate the association between mood and
ASD phenomenology in PMS, including any causal links
between the two phenomena.
A number of caveats must be considered when interpret-
ing the findings in this study. Firstly, the assessment of
ASD phenomenology is somewhat limited, due to the util-
isation of a screening measure rather than a diagnostic
measure; the “gold standard” for assessment of ASD in in-
dividuals with intellectual disability is a combination of
ADOS and ADI-R. However, utilising a brief parent screen-
ing measure reduced time and assessment demands and
conferred the advantage of assessing multiple comparison
groups in order to position the profile of ASD phenomen-
ology in PMS relative to other syndromes [39]. Addition-
ally, the SCQ is recognised as more appropriate for
assessing ASD phenomenology in samples with intellectual
disabilities than other ASD screening tools [38]. Similarly,
the Wessex adaptive behaviour scores were utilised as a
proxy measure for intellectual disability. Whilst it would
have been beneficial to conduct full cognitive assessments
of all of the participants, it would not have been possible
within the scope of this study. Thus, a brief assessment of
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adaptive behaviour was chosen in order to balance the need
to assess intellectual disability and the need to maximise
participants in all the four groups. The limitations imposed
by this method of assessing adaptive functioning should be
considered as a caveat to the present study, particularly as
the Wessex score was used as one of the indices for match-
ing the groups. Future studies should seek to include robust
cognitive assessments of intellectual functioning. Secondly,
despite careful matching of the groups, it was not possible
to reduce all differences in adaptive behaviour. Therefore,
the Down syndrome group were significantly more able
than the PMS, fragile X syndrome and idiopathic ASD sam-
ples. Previous researchers have argued that delineating the
behavioural phenotype of a given genetic syndrome in rela-
tion to multiple other syndromes reduces the need for
chronological or mental age matched comparison groups
[39]. Additionally, the PMS, fragile X syndrome and idio-
pathic ASD groups were well matched for chronological
age and adaptive ability. Nonetheless, the results should be
interpreted with this caveat in mind. Finally, due to the
relatively small PMS sample, there was insufficient statis-
tical power to test causal associations between expressive
speech, adaptive behaviour and ASD scores. Previous re-
search has highlighted that it is important to explore these
associations in samples with genetic syndromes [22]. Cor-
relational evidence from this study indicates that adaptive
behaviour was not associated with SCQ score; however, this
still warrants further exploration in larger sample sizes,
where causal statistical modelling is possible.
The results of this study have a number of important
clinical implications. The results indicate that assessment of
behaviours indicative of low mood should be routine in in-
dividuals with PMS. Research in individuals with severe in-
tellectual disabilities has revealed that low mood scores
may indicate pain and undiagnosed health conditions [40–
42]. There are reports of gastro-oesophageal reflux and
other painful conditions in PMS [1, 15]. Therefore, thor-
ough health assessments should routinely be conducted for
individuals with PMS. The results of this study have impli-
cations for research investigating the genetic underpinnings
of idiopathic ASD. The results demonstrate that those with
high levels of ASD impairment evidence a profile of ASD
impairments that is similar to that of individuals with idio-
pathic ASD. However, the wider PMS sample presents a
more atypical pattern with fewer impairments in repetitive
behaviours. This may suggest that social and communica-
tive impairments would be a useful autism endophenotype
to be investigated in relation to 22q13.3 deletions and
SHANK3 mutations more broadly [16]. Finally, the results
of this study have implications for clinical trials in PMS. To
translate recent pharmacological successes from pre-
clinical studies to human trials [43, 44], nuanced behav-
ioural phenotyping and identification of measures sensitive
to change in behavioural characteristics are required. This
study has identified unique aspects of the behavioural
phenotype of PMS which should be considered as potential
clinical targets (low mood, autism spectrum disorder char-
acteristics) using measures appropriate for the level of intel-
lectual disability present in the syndrome, highlighting both
targets for intervention and measures with sensitivity to de-
tect these difficulties.
In summary, this study has demonstrated that differ-
ences in mood and repetitive behaviour are common in
PMS. Additionally, autism spectrum disorder phenom-
enology is prevalent within the syndrome. The profile of
ASD impairments in the total sample with PMS is het-
erogeneous; the profile within those who meet clinical
threshold for autism is analogous to those with idio-
pathic ASD. The presence of ASD phenomenology is as-
sociated with lower mood in those with PMS.
Conclusions
The results of this study demonstrate that ASD phe-
nomenology is common in PMS and can be considered
to be a component of the behavioural phenotype. These
data support the assertion that SHANK3 mutations
may be causally implicated in the development of ASD-
type behaviours, particularly social and communication
deficits, although further research is required to delin-
eate the specificity of this endophenotype. The results
extended previous studies by demonstrating that whilst
the profile of ASD phenomenology in PMS is atypical,
the profile in those who score above threshold on an
autism screening measure is analogous to idiopathic
ASD. This suggests that ASD-specific interventions
could be usefully applied to groups with PMS who meet
criteria for ASD. Fine-grained analysis of ASD phenom-
enology revealed an emerging dissociation between def-
icits in behaviours indicative of social skill, but relative
preservation in behaviours indicative of social motiv-
ation. This suggests potential targets for psychological
interventions in PMS.
Endnote
1For brevity and to prevent duplication of results from
previously published data, this manuscript will only de-
scribe the differences between the PMS group and other
comparison groups, rather than also describing inter-
comparison group differences.
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